MITF and melanoma: AXL is not essential for sustaining intrinsic resistance, and a transcriptional cell state differentiation associated with low levels of microphthalmia-associated transcription factor (MITF) and elevated levels of nuclear factor of kappa light polypeptide gene enhancer in B cell (NF-κB) may influence melanoma resistance to MAPK pathway inhibitors[101].